Exploiting circulating tumor DNA (ctDNA) to intensify the adjuvant (adj) or post-adj treatment of stage III and highrisk stage II resected colon cancer patients (pts): The ERASE-CRC project by GONO

被引：0
|
作者：
Conca, V. [1 ,2 ]
Vetere, G. [1 ,2 ]
Moretto, R. [3 ]
Lonardi, S. [4 ]
Antoniotti, C. [1 ,2 ]
Germani, M. M. [1 ,2 ]
Pietrantonio, F. [5 ]
Bittoni, A. [6 ]
Carullo, M. [1 ,2 ]
Salvatore, L. [7 ]
Boccaccino, A. [8 ]
Ronzoni, M. [9 ]
Ricagno, G. [10 ]
Toma, I. [11 ]
Cupini, S. [12 ]
Latiano, T. P. [13 ]
Arcangeli, G. [14 ]
Masi, G. [1 ,2 ]
Fassan, M. [15 ]
Cremolini, C. [1 ,2 ]
机构：
[1] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[2] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
[3] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
[4] IOV Ist Oncol Veneto IRCCS, Dept Oncol, Med Oncol 3, Padua, Italy
[5] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[6] IRST Ist Romagnolo Studio Tumori Dino Amadori IRC, Med Oncol, Meldola, Italy
[7] Fdn Policlin Univ Agostino Gemelli IRCC, Dipartimento Oncol, Rome, Italy
[8] Santa Maria Croci Hosp Ravenna AUSL Romagana, Oncol Unit, Ravenna, Italy
[9] IRCCS Osped San Raffaele, Dept Oncol, Milan, Italy
[10] Univ Padua, Veneto Inst Oncol IOV IRCCS, Dept Surg Oncol & Gastroenterol, Med Oncol 1, Padua, Italy
[11] Tricase City Hosp, Dept Oncol & Palliat Care, Cardinale G Panico, Tricase, Italy
[12] Azienda Toscana Nord Ovest Livorno, Div Med Oncol, Dept Oncol, Livorno, Italy
[13] Fdn IRCCS Casa Sollievo Sofferenza, Dept Oncol, San Giovanni Rotondo, Italy
[14] Azienda Osped Spedali Civili Brescia, Oncol Unit, Brescia, Italy
[15] Univ Padua, Surg Pathol Unit, Dept Med DIMED, Padua, Italy
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158TiP
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 43 条
  • [1] Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO
    Conca, Veronica
    Vetere, Guglielmo
    Moretto, Roberto
    Lonardi, Sara
    Antoniotti, Carlotta
    Germani, Marco Maria
    Pietrantonio, Filippo
    Bittoni, Alessandro
    Carullo, Martina
    Salvatore, Lisa
    Boccaccino, Alessandra
    Ronzoni, Monica
    Ricagno, Gianmarco
    Toma, Ilaria
    Cupini, Samanta
    Latiano, Tiziana Pia
    Arcangeli, Giuseppina
    Masi, Gianluca
    Fassan, Matteo
    Cremolini, Chiara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [3] CD3+tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ)
    Francini, Edoardo
    Ou, Fang-Shu
    Lazzi, Stefano
    Petrioli, Roberto
    Multari, Andrea Giovanni
    Pesola, Guido
    Messuti, Luciana
    Colombo, Elena
    Livellara, Virginia
    Bazzurri, Serena
    Cherri, Sara
    Salvatora, Miano
    Wolfe, Eric
    Alberts, Steven R.
    Hubbard, Joleen Marie
    Yoon, Harry H.
    Francini, Guido
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).
    Diehn, Maximilian
    Alizadeh, Ash A.
    Adams, Hans-Peter
    Lee, John J.
    Klassen, Susanne
    Palma, John F.
    Hinzman, Bernd
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Yao, Lijing
    Yaung, Stephanie
    Balasubramanyam, Aarthi
    Rohr, Ulrich Peter
    Rosenthal, Andre
    Kube, Rainer
    Steinmueller, Thomas
    Marusch, Frank
    Mantke, Rene
    Heise, Michael
    Pross, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Ensor, Joe
    Langer, Nathan
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Donald
    Meyer, Janelle Marie
    Sharif, Saima
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 9 - 9
  • [6] CIRCULATING TUMOR DNA MAY GUIDE ADJUVANT TREATMENT DECISIONS IN STAGE II COLON CANCER
    Gambardella, V.
    Martinelliy, E.
    Tarazona, N.
    Cervantes, A.
    ESMO OPEN, 2022, 7 (04)
  • [7] Combine high risk factors with circulating tumor DNA (ctDNA) to assist adjuvant chemotherapy ( ACT) decision in Stage II colorectal cancer (CRC)
    Yuan, Xie Gui
    Miao, Liu
    Li, Huang Meng
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.
    Shah, Purvi K.
    Aushev, Vasily N.
    Ensor, Joe
    Sanchez, Stephanie A.
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Don
    Liu, Minetta C.
    Jurdi, Adham A.
    Aleshin, Alexey
    Meyer, Janelle Marie
    Sharif, Saima
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 15 - 15
  • [9] Circulating tumor DNA (ctDNA) dynamics and treatment responses in chemotherapy-ineligible patients (pts) with unresectable stage III NSCLC from the phase II DUART trial
    Filippi, A. R.
    Garcia-Campelo, M. R.
    Paoli, J-B.
    Kowalski, D. M.
    Bennati, C.
    Borghetti, P.
    Cortinovis, D. L.
    Delmonte, A.
    Genova, C.
    Mroz, R. M.
    Nawrocki, S.
    Toledano, I.
    Tonini, G.
    Stewart, R.
    Zhu, Z.
    Wetherill, G.
    Georgoulia, N. E.
    Perez, I. Diaz
    Dziadziuszko, R.
    ANNALS OF ONCOLOGY, 2024, 35 : 1241 - 1241
  • [10] ?Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial?
    Taieb, Julien
    Benhaim, Leonor
    Puig, Pierre Laurent
    Le Malicot, Karine
    Emile, Jean Francois
    Geillon, Flore
    Tougeron, David
    Manfredi, Sylvain
    Chauvenet, Marion
    Taly, Valerie
    Lepage, Come
    Andre, Thierry
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (07) : 730 - 733
12345